Phase I and pharmacological study of pazopanib in combination with oral topotecan in patients with advanced solid tumours

被引：0
|
作者：
B Milojkovic Kerklaan
M P J Lolkema
L A Devriese
E E Voest
A Nol-Boekel
M Mergui-Roelvink
M Langenberg
K Mykulowycz
J Stoebenau
S Lane
P Legenne
P Wissel
D A Smith
B J Giantonio
J H M Schellens
P O Witteveen
机构：
[1] The Netherlands Cancer Institute,Department of Clinical Pharmacology
[2] The Netherlands Cancer Institute,Division of Molecular Pathology
[3] University Medical Center Utrecht,Department of Medical Oncology
[4] Abramson Cancer Center,undefined
[5] University of Pennsylvania,undefined
[6] GlaxoSmithKline,undefined
[7] Research Triangle Park,undefined
[8] Science Faculty,undefined
[9] Utrecht Institute of Pharmaceutical Sciences (UIPS),undefined
[10] Utrecht University,undefined
来源：
British Journal of Cancer | 2015年 / 113卷
关键词：
Pazopanib; topotecan; ovarian cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：706 / 715
页数：9
相关论文
共 50 条
  • [1] Phase I and pharmacological study of pazopanib in combination with oral topotecan in patients with advanced solid tumours
    Kerklaan, B. Milojkovic
    Lolkema, M. P. J.
    Devriese, L. A.
    Voest, E. E.
    Nol-Boekel, A.
    Mergui-Roelvink, M.
    Langenberg, M.
    Mykulowycz, K.
    Stoebenau, J.
    Lane, S.
    Legenne, P.
    Wissel, P.
    Smith, D. A.
    Giantonio, B. J.
    Schellens, J. H. M.
    Witteveen, P. O.
    BRITISH JOURNAL OF CANCER, 2015, 113 (05) : 706 - 715
  • [2] Phase I study of safety, tolerability, and pharmacokinetics of pazopanib in combination with oral topotecan in patients with advanced solid tumors
    Kerklaan, Bojana Milojkovic
    Lolkema, Martijn P. J. K.
    Devriese, Lot A.
    Voest, Emile E.
    Nol-Boekel, A.
    Mergui-Roelvink, M.
    Mykulowycz, Kristine
    Stoebenau, Joseph E.
    Fang, Lei
    Legenne, Philippe
    Wissel, Paul Stephen
    Smith, Deborah A.
    Giantonio, Bruce J.
    Schellens, Jan H. M.
    Witteveen, Petronella
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [3] Five days of oral topotecan (Hycamtin®), a phase I and pharmacological study in adult patients with solid tumours
    Gerrits, CJH
    Burris, H
    Schellens, JHM
    Planting, AST
    van den Burg, MEL
    Rodriguez, GI
    van Beurden, V
    Loos, WJ
    Hudson, I
    Fields, S
    Verweij, J
    von Hoff, DD
    EUROPEAN JOURNAL OF CANCER, 1998, 34 (07) : 1030 - 1035
  • [4] A Phase I study of pazopanib in combination with gemcitabine in patients with advanced solid tumors
    Plummer, Ruth
    Madi, Ayman
    Jeffels, Melinda
    Richly, Heike
    Nokay, Bahar
    Rubin, Stephen
    Ball, Howard A.
    Weller, Steve
    Botbyl, Jeffrey
    Gibson, Diana M.
    Scheulen, Max E.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (01) : 93 - 101
  • [5] A Phase I study of pazopanib in combination with gemcitabine in patients with advanced solid tumors
    Ruth Plummer
    Ayman Madi
    Melinda Jeffels
    Heike Richly
    Bahar Nokay
    Stephen Rubin
    Howard A. Ball
    Steve Weller
    Jeffrey Botbyl
    Diana M. Gibson
    Max E. Scheulen
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 93 - 101
  • [6] A phase I study of intravenous and oral rucaparib in combination with chemotherapy in patients with advanced solid tumours
    Richard H Wilson
    TR Jeffry Evans
    Mark R Middleton
    L Rhoda Molife
    James Spicer
    Veronique Dieras
    Patricia Roxburgh
    Heidi Giordano
    Sarah Jaw-Tsai
    Sandra Goble
    Ruth Plummer
    British Journal of Cancer, 2017, 116 : 884 - 892
  • [7] A phase I study of intravenous and oral rucaparib in combination with chemotherapy in patients with advanced solid tumours
    Wilson, Richard H.
    Evans, T. R. Jeffry
    Middleton, Mark R.
    Molife, L. Rhoda
    Spicer, James
    Dieras, Veronique
    Roxburgh, Patricia
    Giordano, Heidi
    Jaw-Tsai, Sarah
    Goble, Sandra
    Plummer, Ruth
    BRITISH JOURNAL OF CANCER, 2017, 116 (07) : 884 - 892
  • [8] Phase I Study of Pazopanib in Combination with Weekly Paclitaxel in Patients with Advanced Solid Tumors
    Tan, Antoinette R.
    Dowlati, Afshin
    Jones, Suzanne F.
    Infante, Jeffrey R.
    Nishioka, Jennifer
    Fang, Lei
    Hodge, Jeffrey P.
    Gainer, Shelby D.
    Arumugham, Thangam
    Suttle, A. Benjamin
    Dar, Mohammed M.
    Lager, Joanne J.
    Burris, Howard A., III
    ONCOLOGIST, 2010, 15 (12): : 1253 - 1261
  • [9] Phase I trial of oral Deforolimus in combination with Bevacizumab in patients with advanced solid tumours
    Nemunaitis, J.
    Hochster, H. S.
    Lustgarten, S.
    Turner, C. D.
    Haluska, F.
    Mita, M. M.
    EJC SUPPLEMENTS, 2009, 7 (02): : 137 - 137
  • [10] Oral topotecan (T) on a daily x 5 schedule in combination with intravenous cisplatin (C): A phase I and pharmacological study in patients with advanced solid tumors
    de Jonge, MJA
    Sparreboom, A
    Planting, AST
    Brouwer, E
    van der Burg, MEL
    Hearn, S
    Verweij, J
    ANNALS OF ONCOLOGY, 1998, 9 : 69 - 69
12345